Global Burden of Disease Study 2021 estimates: implications for health policy and research

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00812-2/abstract?utm_campaign=gbdalerts&utm_medium=email&dgcid=hubspot_email_gbdalerts&_hsenc=p2ANqtz-_DfeHLckJcklEFPhtcvNORoUMzQTPfpdYANmdMXOYCVbN-09luiSeAi_L4-iHyCxV0K40zoExm25DdFSvrxvAQwGkYgQ&_hsmi=311643152&utm_content=311597708&utm_source=hs_email Over the past three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has produced several iterations of global estimates for various disease metrics. 1 The latest iteration, GBD 2021, published in The Lancet as a series of Articles, includes estimates of the global disease burden including incidence, prevalence, and disability-adjusted life-years (DALYs) for 371 diseases and injuries, at both the country level and subnational locations between 1990 and 2021. 2